HK Stock MarketDetailed Quotes

06618 JD HEALTH

Watchlist

28.200
+0.150+0.53%

Not Open Dec 20 16:08 CST

90.20BMarket Cap31.44P/E (TTM)

JD HEALTH Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

4.55%28.34B

-4.90%13.27B

14.54%53.53B

34.04%27.11B

--13.95B

52.32%46.74B

48.30%20.23B

58.30%30.68B

55.37%13.64B

78.77%19.38B

Operating income

4.55%28.34B

14.54%53.53B

34.04%27.11B

52.32%46.74B

48.30%20.23B

58.30%30.68B

55.37%13.64B

78.77%19.38B

Cost of sales

-3.52%-21.64B

----

-13.08%-41.66B

-32.24%-20.91B

----

-56.89%-36.84B

-53.05%-15.81B

-62.35%-23.48B

-57.48%-10.33B

-80.14%-14.47B

Operating expenses

-3.52%-21.64B

-13.08%-41.66B

-32.24%-20.91B

-56.89%-36.84B

-53.05%-15.81B

-62.35%-23.48B

-57.48%-10.33B

-80.14%-14.47B

Gross profit

8.01%6.7B

19.95%11.87B

40.51%6.2B

37.43%9.89B

33.47%4.41B

46.37%7.2B

49.15%3.31B

74.85%4.92B

Selling expenses

-17.52%-1.4B

----

-20.91%-2.65B

-28.03%-1.19B

----

-2.90%-2.2B

4.59%-933.3M

-48.74%-2.13B

-79.69%-978.18M

-92.30%-1.43B

Administrative expenses

21.87%-685.06M

----

7.20%-2B

11.09%-876.78M

----

15.12%-2.15B

12.17%-986.16M

-381.25%-2.54B

-1,226.44%-1.12B

-322.01%-527.19M

Research and development expenses

-4.56%-645.02M

----

-14.93%-1.23B

-26.72%-616.86M

----

-19.52%-1.07B

-21.16%-486.8M

-46.60%-892.91M

-44.44%-401.79M

-80.07%-609.07M

Revaluation surplus

----

-1,288.60%-17.54B

-Changes in the fair value of other assets

----

-1,288.60%-17.54B

Impairment and provision

116.10%10.41M

----

28.86%-69.86M

-486.50%-64.66M

----

-156.05%-98.2M

-12.15%-11.03M

-32,679.49%-38.35M

-2,161.01%-9.83M

93.71%-117K

-Other impairment is provision

116.10%10.41M

----

28.86%-69.86M

-486.50%-64.66M

----

-156.05%-98.2M

-12.15%-11.03M

-32,679.49%-38.35M

-2,161.01%-9.83M

93.71%-117K

Operating interest expense

----

-4.24%-9.49M

----

-51.68%-9.1M

-102.28%-4.87M

-75.61%-6M

-38.05%-2.41M

90.38%-3.42M

Special items of operating profit

1.47%-2.48B

----

12.11%-3.14B

-60.77%-2.52B

----

-49.19%-3.58B

-42.77%-1.57B

-33.27%-2.4B

-28.70%-1.1B

-58.11%-1.8B

Operating profit

60.48%1.49B

-38.74%487.32M

248.75%2.76B

118.67%931.36M

795.45M

198.17%792.57M

239.75%425.91M

95.25%-807.33M

94.19%-304.77M

-1,936.07%-17B

Financing income

5.67%989.51M

----

--936.46M

----

Financing cost

8.34%-4.02M

----

---4.39M

----

Share of profits of associates

-26.74%-40.81M

----

26.87%-70.76M

33.70%-32.2M

----

-2.75%-96.76M

-19.82%-48.57M

-22.25%-94.17M

---40.53M

---77.02M

Earning before tax

33.21%2.44B

287.08%2.69B

385.29%1.83B

177.18%695.81M

209.28%377.35M

94.72%-901.49M

93.43%-345.3M

-1,945.30%-17.07B

Tax

-50.41%-404.96M

----

-76.10%-550.47M

-74.39%-269.23M

----

-82.45%-312.58M

-41.76%-154.39M

-5.27%-171.33M

-5.14%-108.91M

-18.71%-162.76M

After-tax profit from continuing operations

30.24%2.03B

459.16%2.14B

600.58%1.56B

135.72%383.23M

149.09%222.96M

93.78%-1.07B

91.53%-454.21M

-1,673.49%-17.23B

Earning after tax

30.24%2.03B

459.16%2.14B

600.58%1.56B

135.72%383.23M

149.09%222.96M

93.78%-1.07B

91.53%-454.21M

-1,673.49%-17.23B

Minority profit

-542.27%-2.8M

----

-66.74%1.04M

206.73%634K

----

353.41%3.12M

-163.80%-594K

229.03%689K

143.04%931K

---534K

Profit attributable to shareholders

30.48%2.04B

463.49%2.14B

598.43%1.56B

135.41%380.11M

149.12%223.55M

93.77%-1.07B

91.51%-455.14M

-1,673.44%-17.23B

Basic earnings per share

30.00%0.65

475.00%0.69

614.29%0.5

134.29%0.12

146.67%0.07

95.51%-0.35

-0.15

-1,633.33%-7.8

Diluted earnings per share

32.65%0.65

466.67%0.68

600.00%0.49

134.29%0.12

146.67%0.07

95.51%-0.35

-0.15

-1,633.33%-7.8

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	4.55%28.34B	-4.90%13.27B	14.54%53.53B	34.04%27.11B	--13.95B	52.32%46.74B	48.30%20.23B	58.30%30.68B	55.37%13.64B	78.77%19.38B
Operating income	4.55%28.34B		14.54%53.53B	34.04%27.11B		52.32%46.74B	48.30%20.23B	58.30%30.68B	55.37%13.64B	78.77%19.38B
Cost of sales	-3.52%-21.64B	----	-13.08%-41.66B	-32.24%-20.91B	----	-56.89%-36.84B	-53.05%-15.81B	-62.35%-23.48B	-57.48%-10.33B	-80.14%-14.47B
Operating expenses	-3.52%-21.64B		-13.08%-41.66B	-32.24%-20.91B		-56.89%-36.84B	-53.05%-15.81B	-62.35%-23.48B	-57.48%-10.33B	-80.14%-14.47B
Gross profit	8.01%6.7B		19.95%11.87B	40.51%6.2B		37.43%9.89B	33.47%4.41B	46.37%7.2B	49.15%3.31B	74.85%4.92B
Selling expenses	-17.52%-1.4B	----	-20.91%-2.65B	-28.03%-1.19B	----	-2.90%-2.2B	4.59%-933.3M	-48.74%-2.13B	-79.69%-978.18M	-92.30%-1.43B
Administrative expenses	21.87%-685.06M	----	7.20%-2B	11.09%-876.78M	----	15.12%-2.15B	12.17%-986.16M	-381.25%-2.54B	-1,226.44%-1.12B	-322.01%-527.19M
Research and development expenses	-4.56%-645.02M	----	-14.93%-1.23B	-26.72%-616.86M	----	-19.52%-1.07B	-21.16%-486.8M	-46.60%-892.91M	-44.44%-401.79M	-80.07%-609.07M
Revaluation surplus	----	----	----	----	----	----	----	----	----	-1,288.60%-17.54B
-Changes in the fair value of other assets	----	----	----	----	----	----	----	----	----	-1,288.60%-17.54B
Impairment and provision	116.10%10.41M	----	28.86%-69.86M	-486.50%-64.66M	----	-156.05%-98.2M	-12.15%-11.03M	-32,679.49%-38.35M	-2,161.01%-9.83M	93.71%-117K
-Other impairment is provision	116.10%10.41M	----	28.86%-69.86M	-486.50%-64.66M	----	-156.05%-98.2M	-12.15%-11.03M	-32,679.49%-38.35M	-2,161.01%-9.83M	93.71%-117K
Operating interest expense	----	----	-4.24%-9.49M	----	----	-51.68%-9.1M	-102.28%-4.87M	-75.61%-6M	-38.05%-2.41M	90.38%-3.42M
Special items of operating profit	1.47%-2.48B	----	12.11%-3.14B	-60.77%-2.52B	----	-49.19%-3.58B	-42.77%-1.57B	-33.27%-2.4B	-28.70%-1.1B	-58.11%-1.8B
Operating profit	60.48%1.49B	-38.74%487.32M	248.75%2.76B	118.67%931.36M	795.45M	198.17%792.57M	239.75%425.91M	95.25%-807.33M	94.19%-304.77M	-1,936.07%-17B
Financing income	5.67%989.51M	----	----	--936.46M	----	----	----	----	----	----
Financing cost	8.34%-4.02M	----	----	---4.39M	----	----	----	----	----	----
Share of profits of associates	-26.74%-40.81M	----	26.87%-70.76M	33.70%-32.2M	----	-2.75%-96.76M	-19.82%-48.57M	-22.25%-94.17M	---40.53M	---77.02M
Earning before tax	33.21%2.44B		287.08%2.69B	385.29%1.83B		177.18%695.81M	209.28%377.35M	94.72%-901.49M	93.43%-345.3M	-1,945.30%-17.07B
Tax	-50.41%-404.96M	----	-76.10%-550.47M	-74.39%-269.23M	----	-82.45%-312.58M	-41.76%-154.39M	-5.27%-171.33M	-5.14%-108.91M	-18.71%-162.76M
After-tax profit from continuing operations	30.24%2.03B		459.16%2.14B	600.58%1.56B		135.72%383.23M	149.09%222.96M	93.78%-1.07B	91.53%-454.21M	-1,673.49%-17.23B
Earning after tax	30.24%2.03B		459.16%2.14B	600.58%1.56B		135.72%383.23M	149.09%222.96M	93.78%-1.07B	91.53%-454.21M	-1,673.49%-17.23B
Minority profit	-542.27%-2.8M	----	-66.74%1.04M	206.73%634K	----	353.41%3.12M	-163.80%-594K	229.03%689K	143.04%931K	---534K
Profit attributable to shareholders	30.48%2.04B		463.49%2.14B	598.43%1.56B		135.41%380.11M	149.12%223.55M	93.77%-1.07B	91.51%-455.14M	-1,673.44%-17.23B
Basic earnings per share	30.00%0.65		475.00%0.69	614.29%0.5		134.29%0.12	146.67%0.07	95.51%-0.35	-0.15	-1,633.33%-7.8
Diluted earnings per share	32.65%0.65		466.67%0.68	600.00%0.49		134.29%0.12	146.67%0.07	95.51%-0.35	-0.15	-1,633.33%-7.8
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks